Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Loperamide hydrochloride product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Loperamide hydrochloride 1mg/5mL s/f liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Loperamide hydrochloride 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely loperamide hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Loperamide hydrochloride 1mg/5mL sugar free syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Loperamide hydrochloride+simethicone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Loperamide 2mg oral lyophilisate tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Product containing loperamide hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Loperamide hydrochloride 2mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely loperamide hydrochloride 133 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Loperamide hydrochloride 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Loperamide hydrochloride 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely loperamide hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely loperamide hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
2 |
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
2 |
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Loperamide hydrochloride 1mg/5mL conventional release oral syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Loperamide hydrochloride 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely loperamide hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely loperamide hydrochloride 133 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely loperamide hydrochloride 133 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
2 |
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
2 |
Loperamide hydrochloride 2 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |
Loperamide hydrochloride 2 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loperamide hydrochloride |
Inferred relationship |
Some |
1 |